R
Raj Persad
Researcher at North Bristol NHS Trust
Publications - 437
Citations - 5649
Raj Persad is an academic researcher from North Bristol NHS Trust. The author has contributed to research in topics: Bladder cancer & Prostate cancer. The author has an hindex of 33, co-authored 431 publications receiving 4686 citations. Previous affiliations of Raj Persad include National Health Service & University of Bristol.
Papers
More filters
Journal ArticleDOI
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
Louise Dickinson,Louise Dickinson,Louise Dickinson,Hashim U. Ahmed,Hashim U. Ahmed,Clare Allen,Jelle O. Barentsz,B. Carey,Jurgen J. Fütterer,Stijn W.T.P.J. Heijmink,Peter Hoskin,Alex Kirkham,Anwar R. Padhani,Raj Persad,Philippe Puech,Shonit Punwani,Aslam Sohaib,Bertrand Tombal,Arnauld Villers,Jan van der Meulen,Jan van der Meulen,Mark Emberton,Mark Emberton,Mark Emberton +23 more
TL;DR: Consensus was reached on a number of areas related to the conduct, interpretation, and reporting of mpMRI for the detection, localisation, and characterisation of prostate cancer.
Journal ArticleDOI
A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
Maurizio Brausi,J. Alfred Witjes,Donald L. Lamm,Raj Persad,Joan Palou,Marc Colombel,Roger Buckley,Mark S. Soloway,Hideyuki Akaza,Andreas Böhle +9 more
TL;DR: The International Bladder Cancer Group built on the existing framework provided by current guidelines, and provided consensus on the definitions of low, intermediate and high risk nonmuscle invasive bladder cancer, as well as practical recommendations for the treatment of patients in each of these risk categories.
Journal ArticleDOI
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
Ashish M. Kamat,Richard Sylvester,Andreas Böhle,Joan Palou,Donald L. Lamm,Maurizio Brausi,Mark S. Soloway,Raj Persad,Roger Buckley,Marc Colombel,J. Alfred Witjes +10 more
TL;DR: The International Bladder Cancer Group has developed formal recommendations regarding definitions, end points, and clinical trial designs for NMIBC to encourage uniformity among studies in this disease.
Journal ArticleDOI
Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells
Jonathan W. Astin,Jennifer Batson,Shereen Kadir,Jessica Charlet,Raj Persad,David Gillatt,Jon Oxley,Catherine D. Nobes +7 more
TL;DR: It is demonstrated that a combinatorial code of Eph receptor activation dictates whether cell migration will be contact inhibited, and the migration of cancer cells can switch from restrained to invasive, depending on the Eph-receptor profile of the cancer cell and the reciprocal ephrin ligands expressed by neighbouring cells.
Journal ArticleDOI
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
Stephanie Guillaumier,Stephanie Guillaumier,Max Peters,Manit Arya,Manit Arya,Manit Arya,Naveed Afzal,Susan C. Charman,Tim Dudderidge,Feargus Hosking-Jervis,Feargus Hosking-Jervis,Richard Hindley,Henry Lewi,Neil McCartan,Neil McCartan,Caroline M. Moore,Caroline M. Moore,Raj Nigam,Chris Ogden,Raj Persad,Karishma Shah,Jan van der Meulen,Jaspal Virdi,Mathias Winkler,Mark Emberton,Mark Emberton,Hashim U. Ahmed,Hashim U. Ahmed,Hashim U. Ahmed +28 more
TL;DR: Focal HIFU therapy for patients with clinically significant prostate cancer that has not spread has a low probability of side effects and is effective at 5 yr, according to a multicentre study of 625 patients undergoing focal therapy using high-intensity focused ultrasound (HIFU).